Knowledge

Array BioPharma

Source 📝

395: 405: 385: 390: 410: 400: 380: 415: 290: 365: 375: 370: 425: 189: 270: 181:
In 1998, the company was founded by Drs. Tony Piscopio, Kevin Koch, David Snitman, and K.C. Nicolaou.
248: 334: 166: 106: 420: 291:"Co-Founder Of Array BioPharma, Inc. To Lead New Korean Out-Sourcing Chemistry Company" 185: 126: 359: 265: 33: 259: 254: 232: 209: 314: 247:(Adagrasib) - KRasG12C mutation inhibitor - Approved 2022, collaboration with 162: 54: 25: 243: 220: 159: 50: 158:
is an American clinical stage, pharmaceutical company that focuses on
237: 225: 214: 213:(Binimetinib) - selective MEK inhibitor - Approved 2018, acquired by 196: 170: 131: 39: 142: 319: 258:(Selumetinib) - MEK1/2 inhibitor - Approved 2020, licensed by 269:(Larotrectinib) - TRK Inhibitor - Approved 2018, licensed by 236:(Encorafenib) - BRAF inhibitor - Approved 2018, acquired by 335:"Pfizer acquires Array BioPharma, valued at $ 11.4 billion" 224:(Tucatinib) - HER2 inhibitor - Approved 2020, owned by 199:
acquired the company for approximately $ 11 billion.
137: 125: 117: 101: 78: 60: 46: 31: 21: 173:after being acquired for $ 11 billion in 2019. 396:Pharmaceutical companies of the United States 8: 406:Biotechnology companies of the United States 386:Pharmaceutical companies established in 1998 16: 391:Biotechnology companies established in 1998 169:. The company is currently a subsidiary of 15: 203:Discovery of FDA Approved Small Molecules 411:Health care companies based in Colorado 401:Companies formerly listed on the Nasdaq 282: 184:In November 2000, the company became a 381:American companies established in 1998 7: 416:Companies based in Boulder, Colorado 14: 366:1998 establishments in Colorado 1: 376:2019 mergers and acquisitions 371:2000 initial public offerings 426:Biopharmaceutical companies 66:; 26 years ago 442: 271:Loxo Oncology (Eli Lilly) 190:initial public offering 121:$ 173.8 million (2018) 323:. November 17, 2000. 249:Mirati Therapeutics 18: 315:"Array IPO up 17%" 228:(Seattle Genetics) 85:Drs. Tony Piscopio 167:Boulder, Colorado 165:headquartered in 153: 152: 107:Boulder, Colorado 433: 350: 349: 347: 346: 331: 325: 324: 311: 305: 304: 302: 301: 287: 149: 146: 144: 74: 72: 67: 19: 441: 440: 436: 435: 434: 432: 431: 430: 356: 355: 354: 353: 344: 342: 333: 332: 328: 313: 312: 308: 299: 297: 289: 288: 284: 279: 205: 179: 156:Array BioPharma 145:.arraybiopharma 141: 113: 109: 97: 70: 68: 65: 53: 36: 17:Array BioPharma 12: 11: 5: 439: 437: 429: 428: 423: 418: 413: 408: 403: 398: 393: 388: 383: 378: 373: 368: 358: 357: 352: 351: 341:. 18 June 2019 326: 306: 281: 280: 278: 275: 274: 273: 262: 251: 240: 229: 217: 204: 201: 195:In June 2019, 186:public company 178: 175: 151: 150: 139: 135: 134: 129: 123: 122: 119: 115: 114: 111: 105: 103: 99: 98: 96: 95: 92: 89: 86: 82: 80: 76: 75: 62: 58: 57: 48: 44: 43: 37: 32: 29: 28: 23: 13: 10: 9: 6: 4: 3: 2: 438: 427: 424: 422: 419: 417: 414: 412: 409: 407: 404: 402: 399: 397: 394: 392: 389: 387: 384: 382: 379: 377: 374: 372: 369: 367: 364: 363: 361: 340: 336: 330: 327: 322: 321: 316: 310: 307: 296: 292: 286: 283: 276: 272: 268: 267: 263: 261: 257: 256: 252: 250: 246: 245: 241: 239: 235: 234: 230: 227: 223: 222: 218: 216: 212: 211: 207: 206: 202: 200: 198: 193: 191: 187: 182: 176: 174: 172: 168: 164: 161: 157: 148: 140: 136: 133: 130: 128: 124: 120: 116: 112:United States 108: 104: 100: 94:K.C. Nicolaou 93: 91:David Snitman 90: 87: 84: 83: 81: 77: 63: 59: 56: 52: 49: 45: 41: 38: 35: 30: 27: 24: 20: 343:. Retrieved 338: 329: 318: 309: 298:. Retrieved 294: 285: 264: 253: 242: 231: 219: 208: 194: 183: 180: 155: 154: 102:Headquarters 22:Company type 260:Astrazeneca 42:: ARRY 360:Categories 345:2020-07-29 300:2020-07-28 277:References 163:medication 88:Kevin Koch 55:Medication 26:Subsidiary 34:Traded as 295:BioSpace 266:VITRAKVI 255:KOSELUGO 233:BRAFTOVI 160:oncology 51:Oncology 47:Industry 339:Rappler 244:KRAZATI 210:MEKTOVI 188:via an 177:History 138:Website 118:Revenue 79:Founder 69: ( 61:Founded 421:Pfizer 238:Pfizer 226:Seagen 221:TUKYSA 215:Pfizer 197:Pfizer 171:Pfizer 132:Pfizer 127:Parent 40:Nasdaq 147:.com 71:1998 64:1998 320:CNN 143:www 362:: 337:. 317:. 293:. 192:. 110:, 348:. 303:. 73:)

Index

Subsidiary
Traded as
Nasdaq
Oncology
Medication
Boulder, Colorado
Parent
Pfizer
www.arraybiopharma.com
oncology
medication
Boulder, Colorado
Pfizer
public company
initial public offering
Pfizer
MEKTOVI
Pfizer
TUKYSA
Seagen
BRAFTOVI
Pfizer
KRAZATI
Mirati Therapeutics
KOSELUGO
Astrazeneca
VITRAKVI
Loxo Oncology (Eli Lilly)
"Co-Founder Of Array BioPharma, Inc. To Lead New Korean Out-Sourcing Chemistry Company"
"Array IPO up 17%"

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.